- Home
- HITI vs VOR Comparison
HITI vs VOR Comparison
Compare HITI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- VOR
- Stock Information
- Founded
- HITI 2009
- VOR 2015
- Country
- HITI Canada
- VOR United States
- Employees
- HITI N/A
- VOR N/A
- Industry
- HITI
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- HITI
- VOR Health Care
- Exchange
- HITI Nasdaq
- VOR Nasdaq
- Market Cap
- HITI 187.8M
- VOR 202.4M
- IPO Year
- HITI N/A
- VOR 2021
- Fundamental
- Price
- HITI $2.35
- VOR $2.76
- Analyst Decision
- HITI Strong Buy
- VOR Buy
- Analyst Count
- HITI 2
- VOR 7
- Target Price
- HITI $4.75
- VOR $3.77
- AVG Volume (30 Days)
- HITI 332.4K
- VOR 46.8M
- Earning Date
- HITI 06-16-2025
- VOR 08-07-2025
- Dividend Yield
- HITI N/A
- VOR N/A
- EPS Growth
- HITI N/A
- VOR N/A
- EPS
- HITI N/A
- VOR N/A
- Revenue
- HITI $398,202,371.00
- VOR N/A
- Revenue This Year
- HITI $12.43
- VOR N/A
- Revenue Next Year
- HITI $11.39
- VOR N/A
- P/E Ratio
- HITI N/A
- VOR N/A
- Revenue Growth
- HITI 9.22
- VOR N/A
- 52 Week Low
- HITI $1.57
- VOR $0.13
- 52 Week High
- HITI $3.62
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- HITI 55.72
- VOR 78.77
- Support Level
- HITI $2.26
- VOR $2.25
- Resistance Level
- HITI $2.44
- VOR $3.29
- Average True Range (ATR)
- HITI 0.08
- VOR 0.52
- MACD
- HITI 0.01
- VOR 0.18
- Stochastic Oscillator
- HITI 71.19
- VOR 82.52
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.